Skip to main content
Clinical Trials/NCT03436108
NCT03436108CompletedNot Applicable

Role of Bisphenol A (BPA) in the Pathogenesis of the Polycystic Ovary Syndrome

Aljazeera Hospital1 site in 1 country220 target enrollmentStarted: February 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
220
Locations
1
Primary Endpoint
the number of participants who will have high level of bisphenol in btheir blood

Study Overview

Brief Summary

Polycystic ovary syndrome (PCOS) is the most common and the most heterogeneous endocrine disorder in premenopausal women. Its prevalence is estimated from 5 to 10% depending on the diagnosis' criteria .

Apart from signs of hyperandrogenism such as acne, hirsutism and hair loss; women with PCOS usually present with menstrual irregularities and fertility problems ..

Detailed Description

Bisphenol A is formed from acetone and phenol, it is used in production of epoxy resin, polyster resins and polyvarbonate resins. Epoxy resins are used in plastics, adhesives, and structural composites .

Humans are at the end of the food chain, thus they are exposed to the highest doses of these compounds. EDs have been detected in human adipose tissue and biological fluids such as: serum, urine, milk and amniotic fluid .

Additionally, it has been proven that BPA can also directly stimulate androgen synthesis in the ovarian theca-interstitial cells. A correlation between increased serum testosterone levels observed in women with PCOS with serum BPA concentrations has also been found .

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age group: 18-40
  • Diagnosed a case of polycystic ovary syndrome

Exclusion Criteria

  • • Female patients with other acute or chronic illness
  • Cardiovascular disease
  • Neoplasms
  • Current smoking, diabetes mellitus,
  • Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).

Outcomes

Primary Outcomes

the number of participants who will have high level of bisphenol in btheir blood

Time Frame: within 6 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahmoud Alalfy

Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Aljazeera Hospital

Study Sites (1)

Loading locations...

Similar Trials